Literature DB >> 11395230

Radiation therapy for superficial esophageal cancer: a comparison of radiotherapy methods.

K Nemoto1, S Yamada, M Hareyama, H Nagakura, Y Hirokawa.   

Abstract

PURPOSE: A comparison of treatment outcomes in response to various methods of radiotherapy for superficial esophageal cancer (SEC) was carried out for a large series of patients. METHODS AND MATERIALS: During the period from March 1987 to November 1998, 147 patients with superficial esophageal cancer received definitive radiation therapy at nine radiotherapy institutions in Japan. Fifty-five patients were treated with external radiation therapy alone, 69 with high-dose-rate intracavitary radiation therapy with or without external radiation therapy, and 23 with low-dose-rate intracavitary radiation therapy and external radiation therapy.
RESULTS: The 5-year survival rates for mucosal and submucosal cancer patients were 62% and 42%, respectively. The 5-year cause-specific survival rates for mucosal and submucosal cancer patients were 81% and 64%, respectively (p = 0.013). There was no statistically significant difference in the survival rates for either mucosal or submucosal cancer patients between treatment groups. Metastasis was observed only in submucosal cancer patients. Esophageal ulcers developed only in patients who received intracavitary radiation therapy, and were especially common in patients treated with a fraction size of 5 Gy or more.
CONCLUSIONS: The use of intracavitary radiation therapy does not influence the survival or local control rate of SEC. Optimal radiotherapy methods for SEC should be determined by a randomized clinical trial.

Entities:  

Mesh:

Year:  2001        PMID: 11395230     DOI: 10.1016/s0360-3016(01)01481-x

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  Clinical outcomes of radiotherapy for esophageal cancer between 2004 and 2008: the second survey of the Japanese Radiation Oncology Study Group (JROSG).

Authors:  Yasumasa Nishimura; Keiichi Jingu; Satoshi Itasaka; Yoshiharu Negoro; Yuji Murakami; Katsuyuki Karasawa; Gen Kawaguchi; Fumiaki Isohashi; Masao Kobayashi; Yoshiyuki Itoh; Takuro Ariga
Journal:  Int J Clin Oncol       Date:  2015-07-16       Impact factor: 3.402

2.  Recommendations of the Spanish Brachytherapy Group of SEOR for HDR endoluminal treatments. Part 1: Oesophagus.

Authors:  Á Rovirosa; J Anchuelo; V Crispin; C Gutiérrez; A Herreros; I Herruzo; J C Menéndez; P Pino; A Polo; S Rodríguez
Journal:  Clin Transl Oncol       Date:  2015-04-17       Impact factor: 3.405

3.  Long-term outcomes of intraluminal brachytherapy in combination with external beam radiotherapy for superficial esophageal cancer.

Authors:  Yuji Murakami; Yasushi Nagata; Ikuno Nishibuchi; Tomoki Kimura; Masahiro Kenjo; Yuko Kaneyasu; Tomoyuki Okabe; Yasutoshi Hashimoto; Yukio Akagi
Journal:  Int J Clin Oncol       Date:  2011-07-12       Impact factor: 3.402

4.  Clinical practice and outcome of radiotherapy for esophageal cancer between 1999 and 2003: the Japanese Radiation Oncology Study Group (JROSG) Survey.

Authors:  Yasumasa Nishimura; Ryuta Koike; Kazuhiko Ogawa; Ryuta Sasamoto; Yuji Murakami; Yoshiyuki Itoh; Yoshiharu Negoro; Satoshi Itasaka; Toru Sakayauchi; Tetsuro Tamamoto
Journal:  Int J Clin Oncol       Date:  2011-05-25       Impact factor: 3.402

5.  Clinical outcomes of definitive radiotherapy for patients with cT1aN0M0 esophageal cancer unsuitable for endoscopic resection and surgery.

Authors:  Terufumi Kawamoto; Naoto Shikama; Shinji Mine; Yasuo Kosugi; Nanae Yamaguchi; Masaki Oshima; Yoichi Muramoto; Keisuke Sasai
Journal:  J Gastrointest Oncol       Date:  2022-04

6.  The role of definitive chemoradiotherapy versus surgery as initial treatments for potentially resectable esophageal carcinoma.

Authors:  Ming-Wei Ma; Xian-Shu Gao; Xiao-Bin Gu; Mu Xie; Ming Cui; Min Zhang; Ling Liu; Huan Yin; Long-Qi Chen
Journal:  World J Surg Oncol       Date:  2018-08-17       Impact factor: 2.754

7.  Comparison of Recurrence Patterns and Salvage Treatments After Definitive Radiotherapy for cT1a and cT1bN0M0 Esophageal Cancer.

Authors:  Terufumi Kawamoto; Naoto Shikama; Shinji Mine; Keisuke Sasai
Journal:  Front Oncol       Date:  2022-07-11       Impact factor: 5.738

8.  Why is a very easy, useful, old technique underused? An overview of esophageal brachytherapy - interventional radiotherapy.

Authors:  Albert Biete; György Kovács; Ángeles Rovirosa; Luca Tagliaferri; Adam Chicheł; Valentina Lancellotta; Yaowen Zhang; Gabriela Antelo; Peter Hoskin; Elzbieta Van Der Steen-Banasik
Journal:  J Contemp Brachytherapy       Date:  2022-06-30

9.  Management of Clinical T1N0M0 Esophageal Cancer.

Authors:  Andrew J Yang; Seo Hee Choi; Hwa Kyung Byun; Hyun Ju Kim; Jinhyun Choi; Yong Chan Lee; Sang Kil Lee; Kyung Ran Park; Chang Geol Lee
Journal:  Gut Liver       Date:  2019-05-15       Impact factor: 4.519

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.